Protocol for the creation and characterization of SARS-CoV-2 variant testing panels using remnant clinical samples

Leda Bassit1, Heather B Bowers1, Morgan Greenleaf2

  • 1The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, USA; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University, Atlanta, GA, USA.

STAR Protocols
|June 21, 2024
PubMed